{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:14:48Z","timestamp":1789766088499,"version":"4.0.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ijbiomac.2017.07.116","type":"journal-article","created":{"date-parts":[[2017,7,23]],"date-time":"2017-07-23T02:02:28Z","timestamp":1500775348000},"page":"993-1000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"P1","title":["A review on protein misfolding, aggregation and strategies to prevent related ailments"],"prefix":"10.1016","volume":"105","author":[{"given":"Tooba Naz","family":"Shamsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teeba","family":"Athar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0005","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ejmech.2016.07.054","article-title":"Protein aggregation and neurodegenerative diseases: from theory to therapy","volume":"124","author":"Kumar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/BC.2006.064","article-title":"Protein aggregation in crowded environments","volume":"387","author":"Ellis","year":"2006","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0015","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1093\/emboj\/19.15.3870","article-title":"Macromolecular crowding perturbs protein refolding kinetics: implications for folding inside the cell","volume":"19","author":"van den Berg","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijbiomac.2015.06.035","article-title":"Biophysical insight into the anti-amyloidogenic behavior of taurine","volume":"80","author":"Chaturvedi","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0025","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1126\/science.1068408","article-title":"Molecular chaperones in the cytosol: from nascent chain to folded protein","volume":"295","author":"Hartl","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0030","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004507","article-title":"Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis","volume":"3","author":"Lindquist","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijbiomac.2015.11.053","article-title":"Comparative insight into surfactants mediated amyloidogenesis of lysozyme","volume":"83","author":"Chaturvedi","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0040","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1141448","article-title":"Adapting proteostasis for disease intervention","volume":"319","author":"Balch","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0045","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1096\/fj.07-099671","article-title":"Molecular and cellular aspects of protein misfolding and disease","volume":"22","author":"Herczenik","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archneurol.2007.56","article-title":"Protein misfolding and neurodegeneration","volume":"65","author":"Soto","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neures.2011.05.008","article-title":"Protein aggregate spreading inneurodegenerative diseases: problems and perspectives","volume":"70","author":"Lee","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.55782\/ane-2004-1490","article-title":"Neurodegenerative aspects ofprotein aggregation","volume":"64","author":"Trzesniewska","year":"2004","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-biochem-061516-044518","article-title":"Protein misfolding diseases","volume":"86","author":"Hartl","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative diseases","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0080","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm1113","article-title":"Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs","volume":"10","author":"Forman","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0085","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.ijbiomac.2014.10.053","article-title":"Characterization of pre-molten globule state of yeast iso-1- cytochrome c and its deletants at pH 6.0 and 25\u00b0C","volume":"72","author":"Haque","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0090","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1080\/07391102.2014.958760","article-title":"In vitro and in silico studies of urea-induced denaturation of yeast iso-1-cytochrome c and its deletants at pH 6.0 and 25\u00b0C","volume":"33","author":"Haque","year":"2014","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0095","first-page":"1","article-title":"Denatured states of yeast cytochrome c induced by heat and guanidinium chloride are structurally and thermodynamically different","author":"Zaidi","year":"2016","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00018-013-1341-1","article-title":"The role of key residues in structure function, and stability of cytochrome-c","volume":"71","author":"Zaidi","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2003.12.008","article-title":"Principles of protein folding, misfolding and aggregation","volume":"15","author":"Dobson","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijbiomac.2016.10.024","article-title":"Nanoparticles-protein interaction: role in protein aggregation and clinical implications","volume":"94","author":"Parveen","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/138920110790909632","article-title":"Heat shock proteins: an overview","volume":"11","author":"Tutar","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/355033a0","article-title":"Protein folding in the cell","volume":"355","author":"Gething","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0125","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Review article Protein folding and misfolding","volume":"426","author":"Dobson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0959-440X(03)00034-4","article-title":"The chemistry of protein synthesis and voyage through the ribosomal tunnel","volume":"13","author":"Jenni","year":"2003","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0135","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(86)90693-8","article-title":"Speculations on the functions of the major heat shock and glucose-regulated proteins","volume":"46","author":"Pelham","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0140","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1021\/ja9644135","article-title":"Stopped-flow photo-CIDNP observation of protein folding","volume":"119","author":"Hore","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0145","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.7886447","article-title":"Navigating the folding routes","volume":"267","author":"Wolynes","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1359-0278(98)00033-9","article-title":"How do small single-domain proteins fold","volume":"3","author":"Jackson","year":"1998","journal-title":"Fold. Des."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0155","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0959-440X(96)80029-7","article-title":"Time-resolved biophysical methods in the study of protein folding","volume":"6","author":"Plaxco","year":"1996","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0160","series-title":"The Cell: A Molecular Approach","author":"Cooper","year":"2000"},{"issue":"3","key":"10.1016\/j.ijbiomac.2017.07.116_bib0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0006-3495(85)83932-1","article-title":"The stabilization of proteins by osmolytes","volume":"47","author":"Arakawa","year":"1985","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0170","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.genom.7.080505.115737","article-title":"Protein misfolding and human disease","volume":"7","author":"Gregersen","year":"2006","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0180","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/bi002156h","article-title":"Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta (25\u201335) amyloid fibril","volume":"40","author":"Konno","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0185","doi-asserted-by":"crossref","first-page":"10150","DOI":"10.1074\/jbc.M107663200","article-title":"A designed system for assessing how sequence affects alpha to beta conformational transitions in proteins","volume":"277","author":"Ciani","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0190","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature01891","article-title":"Rationalization of the effects of mutations on peptide and protein aggregation rates","volume":"424","author":"Chiti","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0195","doi-asserted-by":"crossref","first-page":"43243","DOI":"10.1074\/jbc.M205570200","article-title":"Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides","volume":"277","author":"Tjernberg","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0200","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jmb.2008.05.013","article-title":"Prediction of aggregation-prone regions in structured proteins","volume":"380","author":"Tartaglia","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative diseases","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0210","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M117.774893","article-title":"Key aromatic\/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly","author":"Bakou","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2017.07.116_bib0215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4161\/pri.1.2.4651","article-title":"Protein misfolding and aggregation in ageing and disease","volume":"1","author":"Tuite","year":"2007","journal-title":"Prion"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0220","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1056\/NEJM199906243402507","article-title":"Molecular basis of the neurodegenerative disorders","volume":"340","author":"Martin","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0225","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0197-4580(87)90133-3","article-title":"Neuron numbers in Alzheimer's disease: cell specific pathology","volume":"8","author":"Hyman","year":"1987","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0230","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0235","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","article-title":"Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus","volume":"50","author":"Myers","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0240","first-page":"61","article-title":"Pathology of amyotrophic lateral sclerosis","volume":"36","author":"Hughes","year":"1982","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0245","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005072-199904000-00002","article-title":"Neuronal apoptosis in Creutzfeldt-Jakob disease","volume":"58","author":"Gray","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0250","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1073\/pnas.90.17.7951","article-title":"Apoptosis is induced by beta-amyloid in cultured central nervous system neurons","volume":"90","author":"Loo","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2017.07.116_sbref0255a","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/362543a0","article-title":"Neurotoxicity of a prion protein fragment","volume":"362","author":"Forloni","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.07.116_sbref0255b","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/hmg\/7.9.1355","article-title":"A cellular model that recapitulates major pathogenic steps of Huntington's disease","volume":"7","author":"Lunkes","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01418-5","article-title":"Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0265","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/76216","article-title":"Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis","volume":"6","author":"Yan","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0270","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1073\/pnas.90.2.567","article-title":"Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum","volume":"90","author":"Arispe","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0275","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1074\/jbc.272.1.44","article-title":"Channel formation by a neurotoxic prion protein fragment","volume":"272","author":"Lin","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0280","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","article-title":"Hydrogen peroxide mediates amyloid beta protein toxicity","volume":"77","author":"Behl","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0285","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"alpha-synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0290","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease-a double-edged sword","volume":"35","author":"Wyss-Coray","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0295","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation ofreactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0300","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2990.1995.tb01097.x","article-title":"Reactive microglia in creutzfeldt- Jakob disease","volume":"21","author":"Muhleisen","year":"1995","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0305","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0310","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/13550289909029743","article-title":"Chemokines\/chemokine receptors in the central nervous system and Alzheimer's disease","volume":"5","author":"Xia","year":"1999","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0315","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1046\/j.1471-4159.2000.0741017.x","article-title":"Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia","volume":"74","author":"Yates","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0320","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0325","unstructured":"Inner Body, Brain \u2212human brain diagrams. http:\/\/www.innerbody.com\/image\/nerv02.html, (Accessed 13 April 2017)."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0330","first-page":"263","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer\u2019s Dementia J. Alzhmr Assn."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0335","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0340","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2353\/ajpath.2008.070442","article-title":"Prion diseases: from protein to cell pathology","volume":"172","author":"Kovacs","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0345","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0350","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.bmcl.2013.01.089","article-title":"Recent developments in targeting protein misfolding diseases","volume":"23","author":"Denny","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0355","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jmb.2011.12.062","article-title":"Inhibition of amyloid formation","volume":"421","author":"Hard","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0360","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/cbic.200900666","article-title":"Strategies for the inhibition of protein aggregation in human diseases","volume":"11","author":"Bartolini","year":"2010","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0365","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pneurobio.2003.11.002","article-title":"Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signalling","volume":"71","author":"Sousa","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0370","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.93.26.15051","article-title":"inhibiting transthyretin amyloid fibril formation via protein stabilization","volume":"26","author":"Miroy","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0375","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1002\/j.1460-2075.1996.tb01027.x","article-title":"Chemical chaperones interfere with the formation of scrapie prion protein","volume":"15","author":"Tatzelt","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0380","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.1021\/jm301182j","article-title":"Small molecules that target protein misfolding","volume":"55","author":"Gavrin","year":"2012","journal-title":"J. Med Chem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0385","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0014-5793(01)02486-3","article-title":"Protein misfolding and disease; protein refolding and therapy","volume":"498","author":"Soto","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0390","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0076-6879(06)13015-3","article-title":"Peptide-based inhibitors of amyloid assembly","volume":"413","author":"Sciarretta","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0395","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0798-822","article-title":"Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy","volume":"4","author":"Soto","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0400","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1096\/fj.01-0841fje","article-title":"Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide","volume":"16","author":"Permanne","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0405","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(99)11419-3","article-title":"Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides","volume":"355","author":"Soto","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0410","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1096\/fj.03-1346fje","article-title":"A strategy for designing inhibitors of alphasynuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders","volume":"18","author":"El-Agnaf","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0415","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1110\/ps.051879606","article-title":"Inhibition of insulin fibrillogenesis with targeted peptides","volume":"15","author":"Gibson","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0420","doi-asserted-by":"crossref","first-page":"13203","DOI":"10.1074\/jbc.273.21.13203","article-title":"Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides","volume":"273","author":"Chabry","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0425","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1021\/bi048582a","article-title":"Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions","volume":"43","author":"Porat","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0430","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1074\/jbc.271.15.8545","article-title":"Arrest of beta-amyloid fibril formation by a pentapeptide ligand","volume":"271","author":"Tjernberg","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0435","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1399-3011.2002.11002.x","article-title":"Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Abeta1-40 fibrillogenesis","volume":"60","author":"Gordon","year":"2002","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0440","doi-asserted-by":"crossref","first-page":"25109","DOI":"10.1074\/jbc.M003554200","article-title":"Inhibition of toxicity in the beta-amyloid peptide fragment beta \u2212(25\u201335) using N-methylated derivatives: a general strategy to prevent amyloid formation","volume":"275","author":"Hughes","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0445","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1021\/bi060837s","article-title":"N-Methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure","volume":"45","author":"Kokkoni","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0450","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1021\/ja075356q","article-title":"Design of an N-methylated peptide inhibitor of alpha-synuclein aggregation guided by solid-state NMR","volume":"130","author":"Madine","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0455","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/35094590","article-title":"Interventional strategies against prion diseases","volume":"2","author":"Aguzzi","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0460","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrd769","article-title":"Kelly, Therapeutic strategies for human amyloid diseases","volume":"1","author":"Sacchettini","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0465","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2174\/0929867023370167","article-title":"The challenge of inhibiting Abeta polymerization","volume":"9","author":"LeVine","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0470","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0475","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","article-title":"A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease","volume":"408","author":"Morgan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0480","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","article-title":"A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease","volume":"408","author":"Janus","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0485","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0490","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1471-4159.2001.00592.x","article-title":"Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies","volume":"79","author":"Lambert","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0495","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.4049\/jimmunol.176.11.7071","article-title":"Diagnostic and therapeutic potential of amyloid-reactive IgG antibodies contained in human sera","volume":"176","author":"O'Nuallain","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0500","doi-asserted-by":"crossref","first-page":"13928","DOI":"10.1371\/journal.pone.0013928","article-title":"Amyloid-beta oligomer specificity mediated by the IgM isotype-implications for a specific protective mechanism exerted by endogenous auto-antibodies","volume":"5","author":"Lindhagen-Persson","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0505","doi-asserted-by":"crossref","first-page":"18513","DOI":"10.1371\/journal.pone.0018513","article-title":"Alpha-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients","volume":"6","author":"Yanamandra","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0510","doi-asserted-by":"crossref","first-page":"12254","DOI":"10.1021\/bi801767k","article-title":"Human plasma contains cross-reactive Abeta conformer-specific IgG antibodies","volume":"47","author":"O'Nuallain","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0515","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10875-010-9413-6","article-title":"Anti-amyloidogenic activity of IgGs contained in normal plasma","volume":"30","author":"O'Nuallain","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0520","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1074\/jbc.M109.044321","article-title":"Inherent anti-amyloidogenic activity of human immunoglobulin gamma heavy chains","volume":"285","author":"Adekar","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0525","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neurobiolaging.2004.06.008","article-title":"Human monoclonal antibodies against amyloid-beta from healthy adults","volume":"26","author":"Geylis","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0530","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.autrev.2008.04.010","article-title":"Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders","volume":"7","author":"Neff","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0535","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2006.01.072","article-title":"Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects","volume":"410","author":"Rosenmann","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0540","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1517\/14728222.12.6.693","article-title":"Emerging and potential therapies for Alzheimer\u2019s disease","volume":"12","author":"Griffiths","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0545","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/07853890701206887","article-title":"The workings of the amyloid diseases","volume":"39","author":"Bellotti","year":"2007","journal-title":"Ann. Med."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0550","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/157488908786242461","article-title":"Brain permeablenanoparticles","volume":"3","author":"Chopra","year":"2008","journal-title":"Recent Patents CNS Drug Discov."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0555","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000109760","article-title":"Hsp104: a weapon to combat diverse neurodegenerative disorders","volume":"16","author":"Shorter","year":"2008","journal-title":"Neurosignals"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0560","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1091\/mbc.E15-10-0693","article-title":"Engineering therapeutic protein disaggregases","volume":"27","author":"Shorter","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0565","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnagi.2017.00138","article-title":"Age-dependent protein aggregation initiates amyloid-\u03b2 aggregation","volume":"9","author":"Groh","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0570","first-page":"30067","article-title":"Environmental neurotoxicant manganese regulates exosome-mediated extracellular miRNAs in cell culture model of Parkinson's disease: relevance to \u03b1-synuclein misfolding in metal neurotoxicity","volume":"813X","author":"Harischandra","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0575","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/03639045.2017.1281949","article-title":"Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the proteinaggregation process","volume":"43","author":"Escalona-Rayo","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0580","first-page":"1","article-title":"Mechanisms of protein aggregation and inhibition","author":"Siddiqi","year":"2017","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0585","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijbiomac.2017.05.048","article-title":"Protein aggregation: from background to inhibition strategies","volume":"103","author":"Alam","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0590","doi-asserted-by":"crossref","first-page":"26759","DOI":"10.1038\/srep26759","article-title":"Vitamin k3 inhibits protein aggregation: implication in the treatment of amyloid diseases","volume":"6","author":"Alam","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0595","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijbiomac.2016.11.110","article-title":"Attenuation of amyloid fibrillation in presence of Warfarin: a biophysical investigation","volume":"95","author":"Siddiqi","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0600","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.procbio.2016.05.015","article-title":"Protein misfolding and aggregation: mechanism, factors and detection","volume":"51","author":"Chaturvedi","year":"2016","journal-title":"Process Biochem."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0605","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijbiomac.2017.03.001","article-title":"Vitamin B12 offers neuronal cell protection by inhibiting A\u03b2-42 amyloid fibrillation","volume":"99","author":"Alam","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0610","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.abb.2017.04.005","article-title":"Ascorbic acid inhibits human insulin aggregation and protects against amyloid induced cytotoxicity","volume":"621","author":"Alam","year":"2017","journal-title":"Arch Biochem. Biophys."},{"key":"10.1016\/j.ijbiomac.2017.07.116_bib0615","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ijbiomac.2016.08.035","article-title":"Anti-amyloidogenic behavior and interaction of diallylsulfide with human serum albumin","volume":"92","author":"Siddiqi","year":"2016","journal-title":"Int. J. Biol. Macromol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017321049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017321049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:49:37Z","timestamp":1761432577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813017321049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":124,"alternative-id":["S0141813017321049"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.07.116","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on protein misfolding, aggregation and strategies to prevent related ailments","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.07.116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}